MACKENZIE FINANCIAL CORP
Position in ESPR — Esperion Therapeutics, Inc.
CIK 919859
TORONTO ONTARIO, A6
Position in ESPR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
659,120
+95.6% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $92,574,463 across 16 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,685 | $29,609,949 | |
| 2 | ZTS |
Zoetis Inc.
|
268,075 | $19,263,869 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
2,367,493 | $9,967,145 | |
| 4 | VTRS |
Viatris Inc
|
572,287 | $9,087,917 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
15,849 | $8,587,463 | |
| 6 | CRON |
Cronos Group Inc.
|
1,597,039 | $4,439,768 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
347,299 | $3,472,990 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
91,604 | $3,103,543 |
All Filings in ESPR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 659,120 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | — | 336,992 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | — | 272,958 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | — | 11,700 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | — | 123,115 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | — | 143,252 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | — | 66,287 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | — | 35,254 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | — | 17,218 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | — | 13,391 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | — | 32,618 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | — | 27,277 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | — | 87,337 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | — | 67,843 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||